FDA Approves Veklury (remdesivir) for the Treatment of COVID-19
The Pharma Data
OCTOBER 22, 2020
Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19. .–(BUSINESS WIRE)–Oct.
52 
Let's personalize your content